Medical devices marketing agency in Australia — ARTG-aware, TGA MDR-clean, HCP-first go-to-market

Why Australian medical device teams choose Ichelon

Medical device marketing in Australia sits under a compliance stack most creative agencies never touch. The Therapeutic Goods (Medical Devices) Regulations 2002 govern what a sponsor can advertise, in what form, and to which audience. The ARTG entry defines the intended purpose that every marketing claim must trace back to. The TGA Advertising Code applies to consumer-facing content; the Medicines Australia Code of Conduct-equivalent MTAA Code of Practice covers HCP-facing promotion for member sponsors. Ignore any of these and a product page becomes a Section 41ML breach the moment it goes live.

Ichelon Australia runs medical device marketing with the ARTG entry loaded into the brief. Every product page, HCP campaign, trade-show microsite and post-market vigilance content asset is checked against the current intended purpose, contraindications and warnings before draft. When the ARTG classification changes — a IIb reclassification, a new indication approval, a variation to the essential principles — the content stack updates on the same cycle, not the marketing calendar.

The second reason is HCP demand mapping. Device sales cycles are long, referral-driven and often pass through multiple gatekeepers — the procurement officer, the medical director, the credentialing committee, the theatre nurse manager and the treating clinician. Ichelon's Search Intelligence Engine maps demand at every gatekeeper stage: what does a procurement officer search when comparing capital equipment, what does an OR nurse manager look up before a trial installation, what does a surgeon read the evening before a first-use case. Content is written to those specific search moments.

The third reason is post-market obligation. TGA post-market surveillance is not a marketing problem until an adverse event report appears in a review, a forum thread or a distributor's inbox. Ichelon Australia's monitoring stack watches Google reviews, Reddit, industry forums and clinician private groups (where accessible) and routes qualified adverse events to the sponsor's pharmacovigilance mailbox with a documented turnaround.

What Ichelon delivers for AU medical devices

Serving medical device teams across Australia

Ichelon Australia works with sponsors headquartered in Sydney North Ryde, Melbourne South-East and Brisbane Fortitude Valley, plus distributor networks reaching every state and territory.

First 90 days on an Ichelon Australia device retainer

Three ways to start with Ichelon Australia devices